Biophysical and molecular docking studies of naphthoquinone derivatives on the ATPase domain of human Topoisomerase II
Authors:
- Nonlawat BoonyalaiNBNonlawat Boonyalai
- Pichamon SittikulPSPichamon Sittikul
- Narathip PradidpholNPNarathip Pradidphol
- Ngampong KongkathipNKNgampong Kongkathip
- 1 March 2013
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 67 (2) , 122-128
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Cellular roles of DNA topoisomerases: a molecular perspectiveNature Reviews Molecular Cell Biology, 2002
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzymeBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Catalytic inhibitors of DNA topoisomerase IIBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell deathBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Structural organization of the human TOP2A and TOP2B genesGene, 1998
- Recent developments in DNA topoisomerase II structure and mechanismCurrent Opinion in Structural Biology, 1996
- Drug resistance associated with altered DNA topoisomerase IIAdvances in Enzyme Regulation, 1993
- Bacterial DNA topoisomerase I can relax positively supercoiled DNA containing a single-stranded loopJournal of Molecular Biology, 1985
- E. coli and M. luteus DNA topoisomerase I can catalyze catenation or decatenation of double-stranded DNA ringsCell, 1980